Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (2019 - 2025)

Avidity Biosciences (RNA) has disclosed Shares Outstanding for 4 consecutive years, with $54.4 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Shares Outstanding rose 16.1% year-over-year to $54.4 million, compared with a TTM value of $54.4 million through Sep 2022, up 16.1%, and an annual FY2021 reading of $47.8 million, up 27.11% over the prior year.
  • Shares Outstanding was $54.4 million for Q3 2022 at Avidity Biosciences, up from $52.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $54.4 million in Q3 2022 and bottomed at $2.9 million in Q2 2019.
  • Average Shares Outstanding over 4 years is $32.2 million, with a median of $37.6 million recorded in 2020.
  • The sharpest move saw Shares Outstanding soared 1182.1% in 2020, then grew 0.37% in 2021.
  • Year by year, Shares Outstanding stood at $3.0 million in 2019, then skyrocketed by 1156.91% to $37.6 million in 2020, then grew by 27.11% to $47.8 million in 2021, then rose by 14.01% to $54.4 million in 2022.
  • Business Quant data shows Shares Outstanding for RNA at $54.4 million in Q3 2022, $52.1 million in Q2 2022, and $49.3 million in Q1 2022.